Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program.
Novartis Pharma AG, Basel, Switzerland.
E A
EA
Mueller
J M
JM
Kovarik
D
D
Pittrow
D000284:Administration, Oral; D001327:Autoimmune Diseases / Q000276:immunology*; D002851:Chromatography, High Pressure Liquid; D018592:Cross-Over Studies; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016903:Drug Monitoring; D004655:Emulsions; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007408:Intestinal Absorption; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D014181:Transplantation Immunology
D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine